Clinical Trial Update: Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing extended-release buprenorphine to sublingual buprenorphine for opioid-related disorders in rural settings; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• Buprenorphine (sublingual formulation) (buprenorphine)
• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Yih-Ing Hser | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 3 | Status: ACTIVE_NOT_RECRUITING